Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
|Podcasts|April 19, 2022
Pharmacy Focus Podcast: Pharmacy Tech Talk - Episode 7 - Pharmacy Intervention
In this month's episode, Staci Rush, clinical pharmacy technician at Hometown Pharmacy, discusses pharmacy intervention and how it can reduce hospital readmissions for patients.
Advertisement
In this month's episode, Staci Rush, clinical pharmacy technician at Hometown Pharmacy, discusses pharmacy intervention and how it can reduce hospital readmissions for patients. She mentions what the key warning signs are the pharmacy technicians should be on the look out for.
If you would like to share your Pharmacy Technician Tips, email agallagher@pharmacytimes.com
Advertisement
Related to this article
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association discusses pharmacists’ role in diabetes and CKD care from ASN Kidney Week 2026
A helpful guide for pharmacists if teas, supplements, or cultural foods are part of a patient's regular routine.
Jai Radhakrishnan, MD, discusses why IgG4-related kidney disease is often missed and what MITIGATE subgroup data presented at ASN Kidney Week 2026 show
Real-world data from ASN Kidney Week show GLP-1 RA users with CKD and obesity had lower rates of kidney failure, death, and heart failure exacerbation.
Hiddo J. L. Heerspink, PharmD, PhD, discusses SOLSTICE elecoglipron data, finerenone in FSGS, and glucagon’s kidney effects from ASN Kidney Week 2026.
Pharmacy performance measures should recognize clinical interventions, patient counseling, prescriber collaboration, and outcomes—not prescription volume alone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cystatin C and the Future of Kidney Function Assessment
2
Walgreens Adds Pharmacist Outreach, Coverage Help for GLP-1s
3
GLP-1 RAs Tied to Lower Kidney Failure Risk in Patients With Obesity, CKD
4
Ribociclib Shows Overall Survival Benefit at 6 Years in NATALEE Breast Cancer Trial
5